Efficacy of quinupristin-dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides

Andrea Giacometti, Oscar Cirioni, Roberto Ghiselli, Fiorenza Orlando, Federico Mocchegiani, Alessandra Riva, Maria Simona Del Prete, Vittorio Saba, Giorgio Scalise

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

A rat model was used to investigate the efficacy of quinupristin-dalfopristin (Q-D) in the prevention of vascular prosthetic graft infection due to methicillin-resistant Staphylococcus epidermidis with intermediate resistance to glycopeptides. The in vitro activity of the compound was compared to that of vancomycin by MIC determination and time-kill study. Moreover, the efficacy of collagen-sealed Q-D-soaked Dacron was evaluated in a rat model of graft infection. Graft infections were established in the subcutaneous tissue of the backs of 120 adult male Wistar rats. The in vivo study included a control group, one contaminated group that did not receive any antibiotic prophylaxis, two contaminated groups that received grafts soaked with 10 and 100 μg of Q-D per ml, respectively, and two contaminated groups that received grafts soaked with 10 and 100 μg of vancomycin per ml, respectively. Rats that received Dacron grafts soaked with 100 μg of Q-D per ml showed no evidence of infection (<10 CFU/ml). In contrast, for rats that received Dacron grafts soaked with 10 μg of Q-D per ml and Dacron grafts soaked with 10 or 100 μg of vancomycin per ml, the quantitative graft cultures demonstrated 2.2 × 102 ± 1.3 × 102, 2.2 × 106 ± 1.9 × 105, and 5.6 × 102 ± 0.3 × 102 CFU/ml, respectively. Taken together the results of the study demonstrate that the use of Dacron grafts soaked with Q-D can result in significant bacterial growth inhibition and show that this compound is potentially valuable for prevention of vascular prosthetic graft infection.

Original languageEnglish
Pages (from-to)2885-2888
Number of pages4
JournalAntimicrobial Agents and Chemotherapy
Volume46
Issue number9
DOIs
Publication statusPublished - Sep 2002

Fingerprint

Staphylococcus epidermidis
Glycopeptides
Blood Vessels
Transplants
Polyethylene Terephthalates
Infection
Vancomycin
quinupristin-dalfopristin
Methicillin Resistance
Antibiotic Prophylaxis
Subcutaneous Tissue
Wistar Rats
Collagen

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Efficacy of quinupristin-dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. / Giacometti, Andrea; Cirioni, Oscar; Ghiselli, Roberto; Orlando, Fiorenza; Mocchegiani, Federico; Riva, Alessandra; Del Prete, Maria Simona; Saba, Vittorio; Scalise, Giorgio.

In: Antimicrobial Agents and Chemotherapy, Vol. 46, No. 9, 09.2002, p. 2885-2888.

Research output: Contribution to journalArticle

Giacometti, Andrea ; Cirioni, Oscar ; Ghiselli, Roberto ; Orlando, Fiorenza ; Mocchegiani, Federico ; Riva, Alessandra ; Del Prete, Maria Simona ; Saba, Vittorio ; Scalise, Giorgio. / Efficacy of quinupristin-dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. In: Antimicrobial Agents and Chemotherapy. 2002 ; Vol. 46, No. 9. pp. 2885-2888.
@article{74db9d42d8ca4ee4b82a562996fb36b1,
title = "Efficacy of quinupristin-dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides",
abstract = "A rat model was used to investigate the efficacy of quinupristin-dalfopristin (Q-D) in the prevention of vascular prosthetic graft infection due to methicillin-resistant Staphylococcus epidermidis with intermediate resistance to glycopeptides. The in vitro activity of the compound was compared to that of vancomycin by MIC determination and time-kill study. Moreover, the efficacy of collagen-sealed Q-D-soaked Dacron was evaluated in a rat model of graft infection. Graft infections were established in the subcutaneous tissue of the backs of 120 adult male Wistar rats. The in vivo study included a control group, one contaminated group that did not receive any antibiotic prophylaxis, two contaminated groups that received grafts soaked with 10 and 100 μg of Q-D per ml, respectively, and two contaminated groups that received grafts soaked with 10 and 100 μg of vancomycin per ml, respectively. Rats that received Dacron grafts soaked with 100 μg of Q-D per ml showed no evidence of infection (<10 CFU/ml). In contrast, for rats that received Dacron grafts soaked with 10 μg of Q-D per ml and Dacron grafts soaked with 10 or 100 μg of vancomycin per ml, the quantitative graft cultures demonstrated 2.2 × 102 ± 1.3 × 102, 2.2 × 106 ± 1.9 × 105, and 5.6 × 102 ± 0.3 × 102 CFU/ml, respectively. Taken together the results of the study demonstrate that the use of Dacron grafts soaked with Q-D can result in significant bacterial growth inhibition and show that this compound is potentially valuable for prevention of vascular prosthetic graft infection.",
author = "Andrea Giacometti and Oscar Cirioni and Roberto Ghiselli and Fiorenza Orlando and Federico Mocchegiani and Alessandra Riva and {Del Prete}, {Maria Simona} and Vittorio Saba and Giorgio Scalise",
year = "2002",
month = "9",
doi = "10.1128/AAC.46.9.2885-2888.2002",
language = "English",
volume = "46",
pages = "2885--2888",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "9",

}

TY - JOUR

T1 - Efficacy of quinupristin-dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides

AU - Giacometti, Andrea

AU - Cirioni, Oscar

AU - Ghiselli, Roberto

AU - Orlando, Fiorenza

AU - Mocchegiani, Federico

AU - Riva, Alessandra

AU - Del Prete, Maria Simona

AU - Saba, Vittorio

AU - Scalise, Giorgio

PY - 2002/9

Y1 - 2002/9

N2 - A rat model was used to investigate the efficacy of quinupristin-dalfopristin (Q-D) in the prevention of vascular prosthetic graft infection due to methicillin-resistant Staphylococcus epidermidis with intermediate resistance to glycopeptides. The in vitro activity of the compound was compared to that of vancomycin by MIC determination and time-kill study. Moreover, the efficacy of collagen-sealed Q-D-soaked Dacron was evaluated in a rat model of graft infection. Graft infections were established in the subcutaneous tissue of the backs of 120 adult male Wistar rats. The in vivo study included a control group, one contaminated group that did not receive any antibiotic prophylaxis, two contaminated groups that received grafts soaked with 10 and 100 μg of Q-D per ml, respectively, and two contaminated groups that received grafts soaked with 10 and 100 μg of vancomycin per ml, respectively. Rats that received Dacron grafts soaked with 100 μg of Q-D per ml showed no evidence of infection (<10 CFU/ml). In contrast, for rats that received Dacron grafts soaked with 10 μg of Q-D per ml and Dacron grafts soaked with 10 or 100 μg of vancomycin per ml, the quantitative graft cultures demonstrated 2.2 × 102 ± 1.3 × 102, 2.2 × 106 ± 1.9 × 105, and 5.6 × 102 ± 0.3 × 102 CFU/ml, respectively. Taken together the results of the study demonstrate that the use of Dacron grafts soaked with Q-D can result in significant bacterial growth inhibition and show that this compound is potentially valuable for prevention of vascular prosthetic graft infection.

AB - A rat model was used to investigate the efficacy of quinupristin-dalfopristin (Q-D) in the prevention of vascular prosthetic graft infection due to methicillin-resistant Staphylococcus epidermidis with intermediate resistance to glycopeptides. The in vitro activity of the compound was compared to that of vancomycin by MIC determination and time-kill study. Moreover, the efficacy of collagen-sealed Q-D-soaked Dacron was evaluated in a rat model of graft infection. Graft infections were established in the subcutaneous tissue of the backs of 120 adult male Wistar rats. The in vivo study included a control group, one contaminated group that did not receive any antibiotic prophylaxis, two contaminated groups that received grafts soaked with 10 and 100 μg of Q-D per ml, respectively, and two contaminated groups that received grafts soaked with 10 and 100 μg of vancomycin per ml, respectively. Rats that received Dacron grafts soaked with 100 μg of Q-D per ml showed no evidence of infection (<10 CFU/ml). In contrast, for rats that received Dacron grafts soaked with 10 μg of Q-D per ml and Dacron grafts soaked with 10 or 100 μg of vancomycin per ml, the quantitative graft cultures demonstrated 2.2 × 102 ± 1.3 × 102, 2.2 × 106 ± 1.9 × 105, and 5.6 × 102 ± 0.3 × 102 CFU/ml, respectively. Taken together the results of the study demonstrate that the use of Dacron grafts soaked with Q-D can result in significant bacterial growth inhibition and show that this compound is potentially valuable for prevention of vascular prosthetic graft infection.

UR - http://www.scopus.com/inward/record.url?scp=0036720603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036720603&partnerID=8YFLogxK

U2 - 10.1128/AAC.46.9.2885-2888.2002

DO - 10.1128/AAC.46.9.2885-2888.2002

M3 - Article

VL - 46

SP - 2885

EP - 2888

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 9

ER -